EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.21.91 | Coinfection |
2016768 |
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. |
unassigned |
0 |
| 3.4.21.91 | COVID-19 |
32981460 |
Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
4
0 |
| 3.4.21.91 | COVID-19 |
34097489 |
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. |
therapeutic application
unassigned |
4
0 |
| 3.4.21.91 | Dengue |
1433530 |
Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5. |
therapeutic application
unassigned |
1
0 |
| 3.4.21.91 | Dengue |
8383225 |
Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 3.4.21.91 | Dengue |
9420267 |
Mutagenesis of the NS3 protease of dengue virus type 2. |
ongoing research
therapeutic application
unassigned |
3
2
0 |
| 3.4.21.91 | Dengue |
9598444 |
Monitoring of dengue viruses in field-caught Aedes aegypti and Aedes albopictus mosquitoes by a type-specific polymerase chain reaction and cycle sequencing. |
diagnostic usage
unassigned |
2
0 |
| 3.4.21.91 | Dengue |
9986797 |
Internal processing of hepatitis C virus NS3 protein. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
1
3
2
0 |
| 3.4.21.91 | Dengue |
10026173 |
Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 3.4.21.91 | Dengue |
10355763 |
Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
